This refers to the therapeutic or physiological regulation of the primary metabolic cascade for the essential amino acid tryptophan, which leads to the formation of kynurenine and its downstream metabolites, including neuroactive and immunomodulatory compounds. The pathway’s balance is critical because it dictates the availability of tryptophan for serotonin and melatonin synthesis versus the production of kynurenine pathway metabolites. Dysregulation is often associated with systemic inflammation and neurocognitive dysfunction.
Origin
The concept is rooted in biochemistry and neuroimmunology, recognizing the kynurenine pathway as a crucial intersection between immune activation and neurological function. The etymological focus on ‘modulation’ reflects the clinical goal of steering the metabolic flow toward beneficial or away from detrimental kynurenine metabolites. This pathway is a key link between gut health, inflammation, and brain chemistry.
Mechanism
The pathway is initiated by the enzyme indoleamine 2,3-dioxygenase (IDO), which is highly inducible by pro-inflammatory cytokines like interferon-gamma (IFN-gamma). Increased IDO activity shunts tryptophan away from serotonin production
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.